OGN: The acquisition of Organon & Co. (OGN) by Sun Pharmaceutical Industries Limited for a closing value of $11.75 billion. Sun Pharma will acquire all outstanding shares of Organon for $14 per share, representing a 24.33% premium from the stock’s last close. Earlier this month, Bloomberg reported that Sun Pharmaceutical Industries and Germany’s Grünenthal were among firms vying for Organon. (Press Release)
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok